HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene Set Enrichment Analysis Reveals That Fucoidan Induces Type I IFN Pathways in BMDC.

Abstract
Fucoidan, a sulfated polysaccharide extracted from brown seaweed, has been proposed to effectively treat and prevent various viral infections. However, the mechanisms behind its antiviral activity are not completely understood. We investigate here the global transcriptional changes in bone marrow-derived dendritic cells (BMDCs) using RNA-Seq technology. Through both analysis of differentially expressed genes (DEG) and gene set enrichment analysis (GSEA), we found that fucoidan-treated BMDCs were enriched in virus-specific response pathways, including that of SARS-CoV-2, as well as pathways associated with nucleic acid-sensing receptors (RLR, TLR, NLR, STING), and type I interferon (IFN) production. We show that these transcriptome changes are driven by well-known regulators of the inflammatory response against viruses, including IRF, NF-κB, and STAT family transcription factors. Furthermore, 435 of the 950 upregulated DEGs are classified as type I IFN-stimulated genes (ISGs). Flow cytometric analysis additionally showed that fucoidan increased MHCII, CD80, and CD40 surface markers in BMDCs, indicative of greater antigen presentation and co-stimulation functionality. Our current study suggests that fucoidan transcriptionally activates PRR signaling, type I IFN production and signaling, ISGs production, and DC maturation, highlighting a potential mechanism of fucoidan-induced antiviral activity.
AuthorsSuyoung Choi, Sol A Jeon, Bu Yeon Heo, Ju-Gyeong Kang, Yunju Jung, Pham Thi Thuy Duong, Ik-Chan Song, Jeong-Hwan Kim, Seon-Young Kim, Jaeyul Kwon
JournalNutrients (Nutrients) Vol. 14 Issue 11 (May 27 2022) ISSN: 2072-6643 [Electronic] Switzerland
PMID35684042 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Polysaccharides
  • fucoidan
Topics
  • Antiviral Agents (metabolism, pharmacology)
  • COVID-19
  • Dendritic Cells
  • Humans
  • Polysaccharides (metabolism, pharmacology)
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: